CIK 0001595097
- Non-accelerated filer
- Smaller reporting company
Corbus Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- CRBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464348039
- Phone
- +1 617-963-0103
- Business address
- 500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
- Former names
- SAV Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,758,438
- in 2 filings, $16K under 10b5-1 plans
Net −$1,758,438. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-21 | Moran Sean F. Chief Financial Officer | Exercise or conversion | +87,500 | $1.40 | $123K | 437,110 |
| 2020-12-21 | Moran Sean F. Chief Financial Officer | Sale | −87,500 | $1.75 | $153K | 349,610 |
| 2020-12-21 | Moran Sean F. Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −87,500 | $1.40 | $123K | 87,500 |
| 2020-12-18 | Moran Sean F. Chief Financial Officer | Exercise or conversion | +53,610 | $1.00 | $54K | 403,220 |
| 2020-12-18 | Moran Sean F. Chief Financial Officer | Sale | −53,610 | $1.40 | $75K | 349,610 |
| 2020-12-18 | Moran Sean F. Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −53,610 | $1.00 | $54K | 53,610 |
| 2020-12-16 | Moran Sean F. Chief Financial Officer | Exercise or conversion | +36,923 | $0.17 | $6K | 386,533 |
| 2020-12-16 | Moran Sean F. Chief Financial Officer | Sale | −36,923 | $1.32 | $49K | 349,610 |
| 2020-12-16 | Moran Sean F. Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −36,923 | $0.17 | $6K | 36,923 |
| 2020-11-11 | Cohen Yuval Chief Executive Officer | Purchase | +4,240 | $1.21 | $5K | 75,330 |
| 2020-07-06 | Golumbeski George Director | Grant or award · Stock Option(right to buy) | +81,000 | 81,000 | ||
| 2020-05-20 | Hochman David P Director | Grant or award · Stock Option(right to buy) | +40,500 | 40,500 | ||
| 2020-05-20 | HOLMER ALAN F Director | Grant or award · Stock Option(right to buy) | +40,500 | 40,500 | ||
| 2020-05-20 | Jacques Rachelle Suzanne Director | Grant or award · Stock Option(right to buy) | +40,500 | 40,500 | ||
| 2020-05-20 | Jenkins John Kenneth Director | Grant or award · Stock Option(right to buy) | +40,500 | 40,500 | ||
| 2020-05-20 | CATLIN AVERY W Director | Grant or award · Stock Option(right to buy) | +40,500 | 40,500 | ||
| 2020-05-20 | Salzmann Peter Director | Grant or award · Stock Option(right to buy) | +40,500 | 40,500 | ||
| 2020-03-17 | Millian Craig Stuart Chief Commercial Officer | Purchase | +2,000 | $4.25 | $9K | 12,000 |
| 2020-03-17 | Discordia Robert Paul Chief Operating Officer | Purchase | +2,840 | $3.54 | $10K | 35,490 |
| 2020-03-17 | White Barbara Chief Medical Officer | Purchase | +15,606 | $3.63 | $57K | 206,217 |
Page 12 of 16 · 320 trades